BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3457445)

  • 1. Therapy-induced myelodysplasia and secondary leukaemia.
    Frisch B; Bartl R; Chaichik S
    Scand J Haematol Suppl; 1986; 45():38-47. PubMed ID: 3457445
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromosome abnormalities in secondary myelodysplastic syndromes.
    Bloomfield CD
    Scand J Haematol Suppl; 1986; 45():82-90. PubMed ID: 3515525
    [No Abstract]   [Full Text] [Related]  

  • 3. Secondary myelodysplasia/leukemia complex.
    Papa G; Mauro FR; Cimino G; Pisani F; Tabilio A; Di Lonardo A
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():141-2. PubMed ID: 2653492
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy-induced leukemia -- an underestimated complication of antineoplastic chemotherapy?].
    Dührsen U
    Zentralbl Gynakol; 2005 Aug; 127(4):235-41. PubMed ID: 16037905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelodysplasia and acute leukemia after autologous bone marrow transplantation.
    Armitage JO
    J Clin Oncol; 2000 Mar; 18(5):945-6. PubMed ID: 10694542
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy-related leukemia and myelodysplastic syndrome.
    Kantarjian HM; Keating MJ
    Semin Oncol; 1987 Dec; 14(4):435-43. PubMed ID: 3321448
    [No Abstract]   [Full Text] [Related]  

  • 7. The p53 gene in pediatric therapy-related leukemia and myelodysplasia.
    Felix CA; Hosler MR; Provisor D; Salhany K; Sexsmith EA; Slater DJ; Cheung NK; Winick NJ; Strauss EA; Heyn R; Lange BJ; Malkin D
    Blood; 1996 May; 87(10):4376-81. PubMed ID: 8639798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary myelodysplastic syndromes and leukaemias.
    Levine EG; Bloomfield CD
    Clin Haematol; 1986 Nov; 15(4):1037-80. PubMed ID: 3552347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplasia and acute myeloid leukemia occurring after autologous bone marrow transplantation for lymphoma.
    Traweek ST; Slovak ML; Nademanee AP; Brynes RK; Niland JC; Forman SJ
    Leuk Lymphoma; 1996 Feb; 20(5-6):365-72. PubMed ID: 8833391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype.
    Ben-Yehuda D; Krichevsky S; Caspi O; Rund D; Polliack A; Abeliovich D; Zelig O; Yahalom V; Paltiel O; Or R; Peretz T; Ben-Neriah S; Yehuda O; Rachmilewitz EA
    Blood; 1996 Dec; 88(11):4296-303. PubMed ID: 8943866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic syndrome and acute leukaemia following treatment of soft tissue sarcoma.
    de Graeff A; Vendrik CP; Pinedo HM
    Neth J Med; 1989 Jun; 34(5-6):251-7. PubMed ID: 2671758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
    Haase D; Hanf V; Schulz T
    Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy- and chemotherapy-induced myelodysplasia and acute myeloid leukemia. A review.
    Pedersen-Bjergaard J
    Leuk Res; 1992; 16(1):61-5. PubMed ID: 1732675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic analyses in 89 patients with secondary hematologic disorders--results of a cooperative study.
    Zaccaria A; Alimena G; Baccarani M; Billström R; Carbonell F; Castoldi GL; Fuscaldo K; Hecht F; Hossfeld DK; Mitelman F
    Cancer Genet Cytogenet; 1987 May; 26(1):65-74. PubMed ID: 3828975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Iatrogenic leukemia].
    Nieweg HO
    Ned Tijdschr Geneeskd; 1978 Mar; 122(12):398-401. PubMed ID: 643094
    [No Abstract]   [Full Text] [Related]  

  • 16. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy-related myelodysplastic syndrome (t-MDS)].
    Yoshida Y
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):206-8. PubMed ID: 9851122
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndrome.
    Iurlo A; Mecucci C; Van Orshoven A; Michaux JL; Boogaerts M; Noens L; Bosly A; Louwagie A; Van Den Berghe H
    Cancer Genet Cytogenet; 1989 Dec; 43(2):227-41. PubMed ID: 2598167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy-related myelodysplastic syndromes.
    Rosenbloom B; Schreck R; Koeffler HP
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):707-22. PubMed ID: 1613013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessment.
    Orazi A; Cattoretti G; Soligo D; Luksch R; Lambertenghi-Deliliers G
    Leukemia; 1993 Jun; 7(6):838-47. PubMed ID: 7684797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.